U.S. Independent Diagnostic Testing Facility Market Size, Share & Trends Analysis Report By Service, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
  • 1.4.6. Research Assumption
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. Objectives
  • 1.8.1. Objective - 1
  • 1.8.2. Objective - 2
  • 1.8.3. Objective - 3
• 1.9. List of Secondary Sources
• 1.10. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. U.S. Independent Diagnostic Testing Facility Market
  • 2.1.1. Market Snapshot
  • 2.1.2. Segment Snapshot
    • 2.1.2.1. Service segment outlook
  • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
  • 3.2.1. Market Dynamics
    • 3.2.1.1. Market Driver Analysis
    • 3.2.1.2. Market Restraint Analysis
    • 3.2.1.3. Market Opportunities Analysis
    • 3.2.1.4. Market Challenges Analysis
• 3.3. Regulatory Framework
• 3.4. Business Environment Analysis Tools
  • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis

Chapter 4. Service Business Analysis

• 4.1. U.S. Independent Diagnostic Testing Facility Market: Service Movement Analysis
• 4.2. U.S. Independent Diagnostic Testing Facility Market: Service Segment Dashboard
• 4.3. Service Movement & Market Share Analysis, 2025 & 2033
• 4.4. U.S. Independent Diagnostic Testing Facility Market Estimates & Forecast, by Service
• 4.5. Radiology/Imaging Services
  • 4.5.1. Radiology/imaging services market, 2021 - 2033 (USD Million)
  • 4.5.2. X-Ray
    • 4.5.2.1. X-ray market, 2021 - 2033 (USD Million)
  • 4.5.3. Computed Tomography (CT)
    • 4.5.3.1. Computed tomography (CT) market, 2021 - 2033 (USD Million)
  • 4.5.4. Magnetic Resonance Angiography (MRA)
    • 4.5.4.1. Magnetic resonance angiography (MRA) market, 2021 - 2033 (USD Million)
  • 4.5.5. Magnetic Resonance Imaging (MRI)
    • 4.5.5.1. Magnetic resonance imaging (MRI) market, 2021 - 2033 (USD Million)
  • 4.5.6. Mammography
    • 4.5.6.1. Mammography market, 2021 - 2033 (USD Million)
  • 4.5.7. Ultrasound
    • 4.5.7.1. Ultrasound market, 2021 - 2033 (USD Million)
  • 4.5.8. Position Emission Tomography (PET) Scan
    • 4.5.8.1. Position emission tomography (PET) scan market, 2021 - 2033 (USD Million)
• 4.6. Sleep Studies
  • 4.6.1. Sleep studies market, 2021 - 2033 (USD Million)
• 4.7. Cardiac Monitoring Services
  • 4.7.1. Cardiac monitoring services market, 2021 - 2033 (USD Million)

Chapter 5. Company Landscape

• 5.1. Company Categorization
• 5.2. Company Market Position Analysis, 2025
• 5.3. Strategy Mapping
• 5.4. Company Profiles/Listing
  • 5.4.1. RadNet, Inc.
    • 5.4.1.1. Overview
    • 5.4.1.2. Financial performance
    • 5.4.1.3. Service benchmarking
    • 5.4.1.4. Strategic initiatives
  • 5.4.2. Vitalistics
    • 5.4.2.1. Overview
    • 5.4.2.2. Financial performance
    • 5.4.2.3. Service benchmarking
    • 5.4.2.4. Strategic initiatives
  • 5.4.3. Breathe
    • 5.4.3.1. Overview
    • 5.4.3.2. Financial performance
    • 5.4.3.3. Service benchmarking
    • 5.4.3.4. Strategic initiatives
  • 5.4.4. Texas MRI
    • 5.4.4.1. Overview
    • 5.4.4.2. Financial performance
    • 5.4.4.3. Service benchmarking
    • 5.4.4.4. Strategic initiatives
  • 5.4.5. The Brookwood Diagnostic Center
    • 5.4.5.1. Overview
    • 5.4.5.2. Financial performance
    • 5.4.5.3. Service benchmarking
    • 5.4.5.4. Strategic initiatives
  • 5.4.6. ACS Diagnostics, Inc.
    • 5.4.6.1. Overview
    • 5.4.6.2. Financial performance
    • 5.4.6.3. Service benchmarking
    • 5.4.6.4. Strategic initiatives
  • 5.4.7. Houston MRI & Diagnostic Imaging
    • 5.4.7.1. Overview
    • 5.4.7.2. Financial performance
    • 5.4.7.3. Service benchmarking
    • 5.4.7.4. Strategic initiatives
  • 5.4.8. TestSmarter Inc.
    • 5.4.8.1. Overview
    • 5.4.8.2. Financial performance
    • 5.4.8.3. Service benchmarking
    • 5.4.8.4. Strategic initiatives
  • 5.4.9. Duke University and Duke University Health System
    • 5.4.9.1. Overview
    • 5.4.9.2. Financial performance
    • 5.4.9.3. Service benchmarking
    • 5.4.9.4. Strategic initiatives
  • 5.4.10. Covenant Health Diagnostics
    • 5.4.10.1. Overview
    • 5.4.10.2. Financial performance
    • 5.4.10.3. Service benchmarking
    • 5.4.10.4. Strategic initiatives
  • 5.4.11. AliveCor, Inc.
    • 5.4.11.1. Overview
    • 5.4.11.2. Financial performance
    • 5.4.11.3. Service benchmarking
    • 5.4.11.4. Strategic initiatives
  • 5.4.12. Advanced Cardio Services
    • 5.4.12.1. Overview
    • 5.4.12.2. Financial performance
    • 5.4.12.3. Service benchmarking
    • 5.4.12.4. Strategic initiatives
  • 5.4.13. Diagnostic Medical Testing Inc.
    • 5.4.13.1. Overview
    • 5.4.13.2. Financial performance
    • 5.4.13.3. Service benchmarking
    • 5.4.13.4. Strategic initiatives
  • 5.4.14. K & T Diagnostic, Inc.
    • 5.4.14.1. Overview
    • 5.4.14.2. Financial performance
    • 5.4.14.3. Service benchmarking
    • 5.4.14.4. Strategic initiatives
  • 5.4.15. Vestavia Diagnostic Center (VDC)
    • 5.4.15.1. Overview
    • 5.4.15.2. Financial performance
    • 5.4.15.3. Service benchmarking
    • 5.4.15.4. Strategic initiatives
  • 5.4.16. Advanced Imaging Center
    • 5.4.16.1. Overview
    • 5.4.16.2. Financial performance
    • 5.4.16.3. Service benchmarking
    • 5.4.16.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. independent diagnostic testing facility market revenue estimates and forecast, by service, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 U.S. independent diagnostic testing facility market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Competitive landscape
• Fig. 11 U.S. independent diagnostic testing facility market trends & outlook
• Fig. 12 Market driver relevance analysis (Current & future impact)
• Fig. 13 Market restraint relevance analysis (Current & future impact)
• Fig. 14 Penetration & growth prospect mapping
• Fig. 15 U.S. independent diagnostic testing facility market: Service movement share analysis (USD Million)
• Fig. 16 U.S independent diagnostic testing facility service market: Segment dashboard
• Fig. 17 Radiology/Imaging testing market, 2021 - 2033 (USD Million)
• Fig. 18 X-Ray market, 2021 - 2033 (USD Million)
• Fig. 19 Computed tomography (CT) market, 2021 - 2033 (USD Million)
• Fig. 20 Magnetic resonance angiography (MRA) market, 2021 - 2033 (USD Million)
• Fig. 21 Magnetic resonance imaging (MRI) market, 2021 - 2033 (USD Million)
• Fig. 22 Mammography market, 2021 - 2033 (USD Million)
• Fig. 23 Ultrasound market, 2021 - 2033 (USD Million)
• Fig. 24 Positron emission tomography (PET) Scan. 2021 - 2033 (USD Million)
• Fig. 25 Sleep studies market, 2021 - 2033 (USD Million)
• Fig. 26 Cardiac monitoring services market, 2021 - 2033 (USD Million)
• Fig. 27 Competition categorization
• Fig. 28 Company market position analysis, 2025
• Fig. 29 Strategic framework